ARCHIVES

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

IOM Report Recommends Solutions to Problem of Medication Errors.

July 28, 2006